West Haven

West Haven antivirus-drug developer NanoViricides Inc. has named a Baylor ophthalmology professor to its board of directors.

NanoViricides Inc. says its $2 million payment to retire preferred stock held by one of its biggest stockholders still leaves the West Haven antiviral developer with more than two years' worth of liquidity to fund ongoing drug trials.

West Haven antivirus-drug developer NanoViricides Inc. got another $2.5 million infusion from a sitting investor, giving it cash on hand to sustain another 24 months of operating with no income.

Connecticut's electric utilities will provide a restoration timeline on Thursday morning as they struggle with power outages from Hurricane Sandy, particularly along the shoreline.

After seeing a sudden upturn in the start of foreclosure proceedings in the state in the first...

West Haven drug developer NanoViricides Inc. says its oral flu vaccine has shown to be effective in...

West Haven drug developer NanoViricides Inc. is about to begin human trials in Australia for its anti-flu...

West Haven antiviral drug developer NanoViricides Inc. seated Trumbull certified public accountant and tax adviser Stanley Glick as an independent director on its board.

Universal Hotel Liquidators announced Monday it will relocate its New Haven store to Route 1 in West...

David Director, president of Connecticut Lighting Centers Inc. since 1984, was recently awarded a Medallion for Entrepreneurship...